Back to search

University of Thessaly (UTH)

Μελέτη προγνωστικών και προβλεπτικών παραγόντων καρκίνων ωοθηκών, τραχήλου μήτρας, ενδομητρίου: διερεύνηση των συστημάτων NFkB/NFkB targeted genes και νευροπεπτιδίων (bombesin, ΕΤ-1) - πεπτιδασών (ΝΕΡ)

Abstract

dc:description

Introduction: Gynecological malignancies are one of the leading causes of death from malignancies in the female population. However, ovarian cancer is the leading cause of death from gynecological malignancies, moreover patients with ovarian cancer were more frequently treated at the center where the study was performed. As a result, it was considered to be mandatory, in the era of personalized medicine, the development of new markers of prognostic or even predictive value to the administered chemotherapy for the treatment of epithelial ovarian cancer. Aim: Our study was designed to analyse immunohistochemically the expression of transcription factors NFkB and HIF-1a, in addition to biomarkers of endothelin axis (CD-10, ETAR and ETBR) in patients with ovarian cancer and relate their expression with overall survival and response to therapy. Methods: Ninety four samples from paraffin-embedded tissues from patients with ovarian cancer were included. The final analysis of the samples compared two cohort groups that were dichotomized to positive and negative according to histoscore (either nucleoscore or cytoscore) of each patient. Results: Patients expressing high NFkB nuclear score, high HIF-1a nuclear score, low CD-10 score and high ETAR and ETBR scores had worse overall survival. Moreover, platinum sensitive patients expressed lower nuclear NFkB, higher cytoplasmic HIF-1a, higher CD-10 and lower ETAR expression. NFkB cytoplasmic score and ETAR score were correlated with disease of early stage, while CD-10 histoscore was associated with advanced stages. More importantly, a combination of specific biomarkers was correlated with OS of patients. Conclusion: Our study confirms the prognostic value of CD10 in ovarian carcinoma through its association with endothelin axis, while the last one (ET axis), mediated mainly through ETAR, may also have clinical and therapeutical impact. Finally, the nuclear expression of known transcriptional factors such as HIF-1a and NFkB could be prognostic biomarkers to assess clinical outcome and possibly predict resistance to platinum-based chemotherapy.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Perdikouri, Eleni-Isidora
  • Περδικούρη, Ελένη-Ισιδώρα

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47278

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Perdikouri, Eleni-Isidora; Περδικούρη, Ελένη-Ισιδώρα. Μελέτη προγνωστικών και προβλεπτικών παραγόντων καρκίνων ωοθηκών, τραχήλου μήτρας, ενδομητρίου: διερεύνηση των συστημάτων NFkB/NFkB targeted genes και νευροπεπτιδίων (bombesin, ΕΤ-1) - πεπτιδασών (ΝΕΡ). University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/47278